Headlines

Benchmark International Successfully Facilitated the Transaction Between Colibri Scientific Limited and Biofortuna Ltd

August 24, 2026

Benchmark International is proud to announce the acquisition of Colibri Scientific by Biofortuna.

Colibri Scientific specialises in the management, storage, and coordination of biological samples for clinical trials, supporting pharmaceutical and biotechnology companies with the reliable, compliant, and efficient handling of critical trial materials. These services play a vital role in ensuring the integrity and traceability of clinical samples throughout the therapeutic development lifecycle.

Biofortuna is a specialist laboratory services and diagnostic contract development and manufacturing organisation (CDMO). Biofortuna provides cell line QC testing, custom assay development, contract manufacturing, and sample management services to empower its global partners in healthcare, biotechnology, and academia to advance innovative life sciences and diagnostic applications in health and wellbeing.

Explore the process trusted by business owners worldwide.

This acquisition strengthens Biofortuna’s commitment to supporting innovation across the healthcare and life sciences sectors. By combining expertise in clinical trial sample operations with Biofortuna’s existing capabilities, the enlarged group will offer an expanded portfolio of laboratory and sample management services, increased capacity, and enhanced support for complex clinical trials, while maintaining its highly personalised approach to customer service.

Dr. Nick Ash, CEO of Biofortuna, said: “Colibri Scientific is an excellent business that aligns perfectly with our laboratory analysis and biobanking services. Together, we create a more competitive offering across sample management, storage, and bioanalysis. This acquisition strengthens our capabilities and reflects our strong momentum as we scale our services. I am delighted to welcome the Colibri Scientific team and their customers to Biofortuna.”

Sue Keeler, Colibri Scientific Founder and Head of Clinical Operations at Biofortuna, added: “Joining Biofortuna allows us to expand our integrated services across the therapeutic development pathway while retaining the agility and flexibility our customers value. Together, we can enhance our offering and support more complex, larger-scale international clinical studies.”

Schedule a Call

Americas: Sam Smoot at +1 (813) 898 2350 / [email protected]

Europe: Michael Lawrie at +44 (0) 161 359 4400 / [email protected]

Africa: Anthony McCardle at +27 21 300 2055 / [email protected] 

 

ABOUT BENCHMARK INTERNATIONAL:

Benchmark International is a global M&A firm that provides business owners with creative, value-maximizing solutions for growing and exiting their businesses. Benchmark International has handled transactions across various industries from offices across the world. With decades of M&A experience, Benchmark International’s transaction teams have assisted business owners with achieving their objectives and ensuring the continued growth of their businesses. The firm has also been named the Investment Banking Firm of the Year by The M&A Advisor and the Global M&A Network, as well as the #1 Sell-side Privately Owned M&A Advisor in the World by PitchBook’s and LSEG's Global League Tables.

The content provided by Benchmark International, including articles, blog posts, videos, and other media, is for general informational purposes only and does not constitute legal, financial, investment, or business advice. While we strive for accuracy, the information may be based on third-party sources, market trends, and evolving industry data that are not independently verified or guaranteed to be current or complete. Any opinions expressed are those of the authors and do not necessarily reflect the views of Benchmark International. Market trends, forecasts, and forward-looking statements are inherently uncertain and subject to change. Nothing in our content should be relied upon as a substitute for personalized advice from qualified professionals. Benchmark International disclaims all liability for any loss or damage resulting from reliance on this content. Always consult with appropriate experts before making business decisions.

Share This Post
Categories

Get These Insights Delivered Directly To Your Email

Explore our curated collection today and stay ahead of the curve in M&A.

Related Posts
Benchmark International Successfully Facilitated the Transaction Between National Group Marketing Trust and New Era Life Insurance CompaniesBenchmark International is pleased to announce the successful completion of the acquisition of the book of business of National Group Marketing Trust (NGM), a Dallas-area insurance marketing organization, by New Era Life Insurance Companies, a Houston-based provider of healthcare and insurance solutions.Benchmark International Successfully Facilitated the Transaction Between Cabinet Max Corporation and an Individual InvestorBenchmark International is pleased to announce the successful transaction between Baltimore, MD-based Cabinet Max Corporation, an architectural millwork provider specializing in plastic laminate casework, custom millwork, acrylics, countertops, and other hard surfaces, and an individual investor who has multiple holdings in the construction, manufacturing, and building products sectors.
Not Finding What You're Looking For?
Ready to dive into our featured M&A content and gain valuable insights for your business?